2022
DOI: 10.7759/cureus.28787
|View full text |Cite
|
Sign up to set email alerts
|

Sarcopenia and Endocrine Ageing: Are They Related?

Abstract: Sarcopenia is an illness of the elderly defined by a widespread and gradual decline of skeletal muscle mass and function, with the possibility of negative effects such as poor physical performance, decreased quality of life, and death. Sarcopenia has complicated and multiple pathogeneses. The shift in pathways necessary for muscle regeneration, inflammatory process, and protein synthesis appears to be one of the leading causes of loss of strength and muscle due to age. Researchers have discussed the effects of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 74 publications
0
4
0
Order By: Relevance
“…Endocrine function declines with age because many hormones decrease with age and hormone receptors become less sensitive. A decrease in hormones important for muscle maintenance such as insulin-like growth factor-1 (IGF-1), testosterone, estrogen and dehydroepiandrosterone (DHEA) contributes to sarcopenia (19). In our study, one third of the control group was sarcopenic, which is a signi cant proportion.…”
Section: Discussionmentioning
confidence: 60%
“…Endocrine function declines with age because many hormones decrease with age and hormone receptors become less sensitive. A decrease in hormones important for muscle maintenance such as insulin-like growth factor-1 (IGF-1), testosterone, estrogen and dehydroepiandrosterone (DHEA) contributes to sarcopenia (19). In our study, one third of the control group was sarcopenic, which is a signi cant proportion.…”
Section: Discussionmentioning
confidence: 60%
“…history of hypothalamic/pituitary disorders, surgery and/or cranial irradiation to this region in the brain), and with the aim to offer treatment when the diagnosis is confirmed [70][71][72]. However, the clinical benefit of initiating GH therapy in older patients is a matter of debate [73]. Moreover, cut-off values could be different, as reported by Colao et al [74], which found that individuals older than 65 yr have lower cut-off points than do middle-aged adults.…”
Section: Somatotropic Axis Pathology and Treatment In Agingmentioning
confidence: 99%
“…Some hormones are integral for the growth and maintenance of skeletal muscle, including insulin-like growth factor-1, dehydroepiandrosterone, testosterone and oestrogen, all of which decrease with increasing age [106] and may contribute to sarcopenia and frailty [107]. Men with low free testosterone are 68% more likely to develop mobility limitation than men with normal free testosterone [108].…”
Section: Hormone Replacementmentioning
confidence: 99%